Clinical Trial Update: Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study [Phase 4]

View source ↗

Summary

Completed Phase 4 feasibility trial from Heidelberg University evaluating mistletoe extract in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Mistletoe extract (Viscum album extract)

Snippet

Sponsor: Heidelberg University | Conditions: Metastatic Breast Cancer | Phase 4 | Status: COMPLETED